Paul, Weiss advised General Atlantic in its investment in Biotheus, a Chinese clinical-stage biotechnology company which focuses on antibody-based therapeutics, in a financing round. General Atlantic co-led this round of financing with IDG Capital.
The Paul, Weiss team included corporate partners Judie Ng Shortell and Tong Yu; and antitrust counsel Marta Kelly.
Related Insights
Private Equity M&A
September 02, 2025
Apollo Completes Acquisition of Bridge Investment Group
Private Equity M&A
September 02, 2025